Inhalers Segment is expected to be the fastest growing during the forecast period for Europe Medical Polyoxymethylene Market.
According to a new market research study on “Europe Medical Polyoxymethylene Market to 2028 - COVID-19 Impact and Analysis and Forecast by: Application,” is expected to reach US$ 17,165.62 thousand by 2028 from US$ 12,143.40 thousand in 2020. The market is estimated to grow at a CAGR of 4.4% from 2020 to 2028. The report provides trends prevailing in the Europe medical polyoxymethylene market along with the drivers and restraints pertaining to the market growth. Amplified use of medical POM in diversified application bases is the major factor driving the growth of the Europe medical polyoxymethylene market. However, issues associated with the rigorous regulations on use of thermoplastics and competition from traditional materials hinder the growth of Europe medical polyoxymethylene market.
The Europe medical polyoxymethylene market is segmented into application, and country. On the basis of application, the Europe medical polyoxymethylene market is categorized into dialysis machine, handles for surgical instruments, inhalers, insulin pen, and others. Insulin pen segment dominated the market in 2019. Further, the inhalers segment is expected to be the fastest growing segment during the forecasted period.
In Europe, currently the UK and Russia, followed by France, Spain, Italy, and Germany, are the hardest-hit countries by the COVID-19 pandemic. These countries are estimated to suffer an economic hit due to a lack of revenue from various industries. Other member states have implemented drastic measures and travel restrictions, including partial closing of their borders. The ongoing COVID-19 pandemic has drastically altered the growth status of the medical polyoxymethylene industry. The outbreak has distorted operational efficiency and disrupted the value chains due to the sudden shutdown of national and international boundaries, creating revenue loss and damage. The disturbed value chain has had a negative impact on raw material supply. However, as the economies are planning to revive their operations, the demand for medical polyoxymethylene is expected to rise in the coming months. However, the focus over just-in-time production is another factor hindering the medical polyoxymethylene market growth across the Europe region.
BASF SE; Celanese Corporation; DuPont de Nemours, Inc.; Ensinger; Kolon Plastics; Korea Engineering Plastics Co. Ltd.; LG Chem; Mitsubishi Chemical Corporation; and Polyplastics Co. Ltd. are among the leading companies in the Europe medical polyoxymethylene market. The companies are focused on adopting organic growth strategies such as product launches and expansions to sustain their position in the dynamic market. For instance, in 2021, Polyplastics Group expanded its DURACON (R) polyoxymethylene (POM) PM series portfolio with the development of a new high-flow grade for drug contact and delivery applications for the medical and healthcare market. The new grade, DURACON PM27S01N, offers reduced wall thickness, miniaturization, and lower weight for various medical devices that are becoming increasingly complicated and highly functional.
According to a new market research study on “Europe Medical Polyoxymethylene Market to 2028 - COVID-19 Impact and Analysis and Forecast by: Application,” is expected to reach US$ 17,165.62 thousand by 2028 from US$ 12,143.40 thousand in 2020. The market is estimated to grow at a CAGR of 4.4% from 2020 to 2028. The report provides trends prevailing in the Europe medical polyoxymethylene market along with the drivers and restraints pertaining to the market growth. Amplified use of medical POM in diversified application bases is the major factor driving the growth of the Europe medical polyoxymethylene market. However, issues associated with the rigorous regulations on use of thermoplastics and competition from traditional materials hinder the growth of Europe medical polyoxymethylene market.
The Europe medical polyoxymethylene market is segmented into application, and country. On the basis of application, the Europe medical polyoxymethylene market is categorized into dialysis machine, handles for surgical instruments, inhalers, insulin pen, and others. Insulin pen segment dominated the market in 2019. Further, the inhalers segment is expected to be the fastest growing segment during the forecasted period.
In Europe, currently the UK and Russia, followed by France, Spain, Italy, and Germany, are the hardest-hit countries by the COVID-19 pandemic. These countries are estimated to suffer an economic hit due to a lack of revenue from various industries. Other member states have implemented drastic measures and travel restrictions, including partial closing of their borders. The ongoing COVID-19 pandemic has drastically altered the growth status of the medical polyoxymethylene industry. The outbreak has distorted operational efficiency and disrupted the value chains due to the sudden shutdown of national and international boundaries, creating revenue loss and damage. The disturbed value chain has had a negative impact on raw material supply. However, as the economies are planning to revive their operations, the demand for medical polyoxymethylene is expected to rise in the coming months. However, the focus over just-in-time production is another factor hindering the medical polyoxymethylene market growth across the Europe region.
BASF SE; Celanese Corporation; DuPont de Nemours, Inc.; Ensinger; Kolon Plastics; Korea Engineering Plastics Co. Ltd.; LG Chem; Mitsubishi Chemical Corporation; and Polyplastics Co. Ltd. are among the leading companies in the Europe medical polyoxymethylene market. The companies are focused on adopting organic growth strategies such as product launches and expansions to sustain their position in the dynamic market. For instance, in 2021, Polyplastics Group expanded its DURACON (R) polyoxymethylene (POM) PM series portfolio with the development of a new high-flow grade for drug contact and delivery applications for the medical and healthcare market. The new grade, DURACON PM27S01N, offers reduced wall thickness, miniaturization, and lower weight for various medical devices that are becoming increasingly complicated and highly functional.
The report segments the Europe Medical Polyoxymethylene Market as follows:
Europe Medical Polyoxymethylene Market - By Application
- Dialysis Machine
- Handles for Surgical Instruments
- Inhalers
- Insulin Pen
- Others
Europe Medical Polyoxymethylene Market - By Country
- Germany
- France
- Italy
- UK
- Russia
- Rest of Europe
Reasons to buy:
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the Europe Medical Polyoxymethylene Market
- Highlights key business priorities in order to assist companies to realign their business strategies
- The key findings and recommendations highlight crucial progressive industry trends in the Europe Medical Polyoxymethylene market, thereby allowing players across the value chain to develop effective long-term strategies
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
- Scrutinize in-depth Europe market trends and outlook coupled with the factors driving Medical Polyoxymethylene market, as well as those hindering it
- Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing and distribution
Frequently Asked Questions about the European Medical Polyoxymethylene Market
What is the estimated value of the European Medical Polyoxymethylene Market?
What is the growth rate of the European Medical Polyoxymethylene Market?
What is the forecasted size of the European Medical Polyoxymethylene Market?
Who are the key companies in the European Medical Polyoxymethylene Market?
Report Attribute | Details |
---|---|
No. of Pages | 97 |
Published | July 2021 |
Forecast Period | 2021 - 2028 |
Estimated Market Value ( USD | $ 12143.4 Million |
Forecasted Market Value ( USD | $ 17165.62 Million |
Compound Annual Growth Rate | 4.4% |
Regions Covered | Europe |
Table of Contents
1. Introduction
3. Research Methodology
4. Europe Medical Polyoxymethylene Market Landscape
5. Europe Medical POM Market - Key Market Dynamics
6. Medical Polyoxymethylene - Europe Market Analysis
7. Europe Medical Polyoxymethylene Market Analysis - by Application
8. Europe Medical POM Market - Country Analysis
9. Impact of COVID-19 Pandemic on Europe Medical POM Market
10. Company Profiles
11. Appendix
List of Tables
List of Figures
Companies Mentioned
A selection of companies mentioned in this report includes:
- BASF SE
- Celanese Corporation
- DuPont de Nemours, Inc.
- Ensinger
- Kolon Plastics
- Korea Engineering Plastics Co., Ltd.
- LG Chem
- Mitsubishi Chemical Corporation
- Polyplastics Co., Ltd.